North America Pharmaceutical Glass Vials And Ampoules Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Market Size (2024) | USD 1.32 Billion |
| Market Size (2029) | USD 1.82 Billion |
| CAGR (2024 - 2029) | 5.42 % |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
North America Pharmaceutical Glass Vials And Ampoules Market Analysis
The North America Pharmaceutical Glass Vials And Ampoules Market size is estimated at USD 1.32 billion in 2024, and is expected to reach USD 1.82 billion by 2029, growing at a CAGR of 5.42% during the forecast period (2024-2029).
- The pharmaceutical industry is one of the most innovative industries in the region, with a robust development and manufacturing facility for generic drugs. Furthermore, the introduction of stringent laws to enhance the quality and integrity of domestically manufactured drugs in the region is leading to an increase in the use of glass for pharmaceutical packaging products.
- A rise in the usage of glass for pharmaceutical vials and ampoules is attributed to the advent of strict legislation designed to improve the integrity and quality of pharmaceuticals produced domestically. The pharmaceutical industry’s growing need for sterile medical packaging products is anticipated to fuel the market's expansion throughout the forecast period.
- Glass remains a preferred material for pharmaceutical packaging due to its chemical durability and compatibility with various chemical compositions. Glass vials and ampoules offer enhanced transparency, facilitating easy viewing and monitoring of contents. Additionally, glass provides superior protection as it is chemically resistant to most pharmaceuticals and relatively impermeable to air and moisture.
- Furthermore, the increasing demand for sterile medical packaging products from pharmaceutical industries would further drive the growth of the studied market during the forecast period.
- The rising demand for injectable pharmaceuticals significantly boosts the growth of glass vials and ampoules. The robust demand for oncology and other high-potency drugs, such as antibody conjugates, steroids, and IV fluids requiring rapid onset of action, is expected to be a key growth driver.
- The pharmaceutical industry is heavily regulated, with stringent requirements for packaging materials to ensure safety and efficacy. Compliance with these regulations can be time-consuming and costly for manufacturers, potentially limiting the market’s growth.
North America Pharmaceutical Glass Vials And Ampoules Market Trends
Ampoules to Hold Significant Market Share
- Ampoules are commonly used for vaccines, biologics, and injectable medications. The increasing demand for vaccines, coupled with the rising prevalence of chronic diseases, contributes to the growth of the pharmaceutical packaging industry. As a result, the market for glass ampoules is expected to witness a substantial increase.
- The surge in demand for vaccine packaging solutions is aided by consumers' high number of vaccines, and the major vaccination drives are organized by mainstream organizations like WHO and UNICEF. This has led to a significant increase in demand for glass ampoules in end-use sectors such as hospitals, diagnostic centers, research programs, and other healthcare units.
- Stringent regulatory requirements for pharmaceutical packaging, especially for vaccines, often favor using glass due to its chemical inertness and the ability to withstand sterilization processes. This compliance drives the demand for glass ampoules in pharmaceutical packaging. Ensuring an adequate supply of pharmaceutical glass ampoules for the vaccine distribution is crucial for a response's success.
- Governments and pharmaceutical companies in the region are placing hundreds of millions of orders and urging primary packaging glass manufacturers to increase their production capacity.
- The International Trade Centre states that the United States of America accounts for 2.6% of global exports of glass ampoules (HS Code - 701010). In 2023, United States total exports reached USD 4,830 thousand. Of this total, USD 2064 thousand were shipped to Japan, making it one of the primary destinations. Additionally, USD 1,232 thousand were exported to Mexico.
- With such a significant portion of exports going to key markets, there may be increased interest from investors and stakeholders in the ampoules packaging sector. This can lead to the developing of new facilities, advanced manufacturing processes, and research into new packaging solutions within North America.
United States to Hold Significant Market Share
- The United States is one of the major packaging markets globally, and many vital players produce glass vials and ampoules for pharmaceuticals. As the economy continuously grows, increasing consumer spending on healthcare and medicines drives the demand for glass packaging solutions.
- Companies that comply with FDA regulations are better positioned to market their products, which increases demand for packaging solutions that meet these standards. Pharmaceutical glass vials and ampoules that adhere to FDA regulations for safety features, such as child resistance and tamper evidence, are expected to witness higher demand.
- According to The Pharmaceutical Research and Manufacturers of America, in 2023, its member companies' research and development (R&D) expenditure reached USD 71.34 billion compared with 2019, which was USD 64.35 billion.
- As pharmaceutical companies invest more in R&D, they may develop new formulations and delivery methods that require specialized vials. For instance, biologics and complex vaccines often require specific types of vials, such as those made from materials that can preserve sensitive components.
- Higher health expenditure typically correlates with increased pharmaceutical investment, including new drugs and biologics. This will drive the demand for pharmaceutical glass vials and ampoules to store and deliver these products.
- According to the Centers for Medicare & Medicaid Services, the total health expenditure of the United States is forecasted to reach USD 6.93 trillion in 2030, compared with USD 4.8 trillion in 2023.
- With greater spending, healthcare services and facilities, including hospitals, clinics, and vaccination centers, are expected to expand. This expansion will lead to a higher need for pharmaceutical packaging to manage and distribute medications and vaccines, including glass vials and ampoules.
North America Pharmaceutical Glass Vials And Ampoules Industry Overview
The North America pharmaceutical glass vials and ampoules market is fragmented, with major players like Schott Pharma (Schott AG), Gerresheimer AG, Berlin Packaging, and Pacific Vial Manufacturing Inc. Players in the market are adopting strategies such as partnerships and acquisitions to enhance their product offerings and gain sustainable competitive advantage.
North America Pharmaceutical Glass Vials And Ampoules Market Leaders
-
Schott Pharma (Schott AG)
-
Gerresheimer AG
-
Berlin Packaging
-
Pacific Vial Manufacturing Inc.
-
SGD SA
*Disclaimer: Major Players sorted in no particular order
North America Pharmaceutical Glass Vials And Ampoules Market News
- March 2024: SCHOTT Pharma, a player in pharmaceutical drug containment solutions and delivery systems, planned to construct the first United States facility for manufacturing prefillable polymer syringes. The project will involve a total investment of USD 371 million and create 401 new jobs in the region. Groundbreaking is expected by the end of 2024, with operations projected to commence in 2027. The company may also consider manufacturing vials and ampoules in the future.
- January 2024: SCHOTT Pharma developed glass vials specifically designed for deep-cold storage of medications. These vials are crucial for preserving life-saving vaccines, including gene therapy and mRNA treatments, which require freezing and transportation at temperatures as low as -80°C. Traditional vials are susceptible to breakage due to the extreme thermal stress and other factors involved in the freezing and thawing. This breakage often leads to significant drug loss and costly production delays.
- October 2023: Gerresheimer, a global partner for the pharmaceutical and biotechnology industries, launched Cyclic Olefin Polymer (COP) vials. These vials offer an effective solution for filling and storing highly sensitive biologics. The COP vials are suitable for mRNA active ingredients at temperatures as low as -80°C and can withstand cryogenic conditions.
North America Pharmaceutical Glass Vials And Ampoules Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET INSIGHTS
4.1 Market Overview
4.2 Industry Attractiveness - Porter's Five Forces Analysis
4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Consumers
4.2.3 Threat of New Entrants
4.2.4 Threat of Substitute Products
4.2.5 Intensity of Competitive Rivalry
4.3 Export Import Data of Glass Ampoules for Major Economies, Trade Value HS code: 701010
4.4 Overview on Pharmaceutical Glass Types (Type I, Type II, and Type III)
4.5 Overview on Pharmaceuticals Glass Vials and Ampoules Regulations
5. MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Rapid Growth in Biopharmaceutical Driving Demand for Glass Vials and Ampoules
5.1.2 Heightened Emphasis on Drug Safety and Compliance
5.2 Market Restraints
5.2.1 Production Cost Challenges in Glass Vial and Ampoule Manufacturing
6. MARKET SEGMENTATION
6.1 By Product Type
6.1.1 Vials
6.1.2 Ampoules
6.2 By Country
6.2.1 United States
6.2.2 Canada
7. COMPETITIVE LANDSCAPE
7.1 Company Profiles
7.1.1 Schott Pharma (Schott AG)
7.1.2 Gerresheimer AG
7.1.3 Berlin Packaging
7.1.4 Pacific Vial Manufacturing Inc.
7.1.5 SGD SA
7.1.6 Corning Incorporated
7.1.7 Waters Corporation
7.1.8 Accu-Glass LLC
7.1.9 NIPRO Corporation
7.1.10 J. Penner Corporation
- *List Not Exhaustive
8. INVESTMENT ANALYSIS
9. FUTURE OUTLOOK OF THE MARKET
North America Pharmaceutical Glass Vials And Ampoules Industry Segmentation
The scope of the study characterizes the pharmaceutical glass vials and ampoules market based on product type, including vials and ampoules. A vial is a compact container containing liquid medications, serums, and pharmaceutical compounds. An ampoule, a smaller variant, serves as a single-dose vial with a sealed neck. The research examines underlying growth influencers and significant industry vendors, all of which help to support market estimates and growth rates throughout the anticipated period. The market estimates and projections are based on the base year factors and arrived at top-down and bottom-up approaches.
The North America pharmaceutical glass vials and ampoules market is segmented by product type (vials, ampoules) and country (United States, Canada). The market sizes and forecasts are provided in terms of value (USD) for all the above segments.
| By Product Type | |
| Vials | |
| Ampoules |
| By Country | |
| United States | |
| Canada |
North America Pharmaceutical Glass Vials And Ampoules Market Research FAQs
How big is the North America Pharmaceutical Glass Vials And Ampoules Market?
The North America Pharmaceutical Glass Vials And Ampoules Market size is expected to reach USD 1.32 billion in 2024 and grow at a CAGR of 5.42% to reach USD 1.82 billion by 2029.
What is the current North America Pharmaceutical Glass Vials And Ampoules Market size?
In 2024, the North America Pharmaceutical Glass Vials And Ampoules Market size is expected to reach USD 1.32 billion.
Who are the key players in North America Pharmaceutical Glass Vials And Ampoules Market?
Schott Pharma (Schott AG), Gerresheimer AG, Berlin Packaging, Pacific Vial Manufacturing Inc. and SGD SA are the major companies operating in the North America Pharmaceutical Glass Vials And Ampoules Market.
What years does this North America Pharmaceutical Glass Vials And Ampoules Market cover, and what was the market size in 2023?
In 2023, the North America Pharmaceutical Glass Vials And Ampoules Market size was estimated at USD 1.25 billion. The report covers the North America Pharmaceutical Glass Vials And Ampoules Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the North America Pharmaceutical Glass Vials And Ampoules Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
North America Pharmaceutical Glass Vials And Ampoules Industry Report
Statistics for the 2024 North America Pharmaceutical Glass Vials And Ampoules market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. North America Pharmaceutical Glass Vials And Ampoules analysis includes a market forecast outlook for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
